Brought to you by 
Cubist and Syrrx look for anti-infectives
22 Aug 2001
Executive Summary
Cubist (anti-infectives) and Syrrx (protein structure) will combine their respective technologies to look for new anti-infectives, including antibiotics to fight bacteria resistant to current drugs.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- Includes Equity
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com